Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Approved Products_2004.xls Number A pproval Date Trade Name Generic/ Chemical name Indication Company 1 Oct- 82 Humulin Human Insulin Type I Diabetes Lilly / Genentech 2 Oct- 85 Protro pin Human Growth Hormone Hypoptuitary dwarfism Genentech 3 Jun- 86 Intron A Interferon Al pha 2B Hairy Cell Leukemia Schering Plough / Biogen 4 Jun- 86 OKT- 3 Anti CD3 Mab Acute Trans plant Rejection JNJ / OrthoBiotech 5 Jun- 86...
author: Reijer
Approved Products_2004.xls page 3
author: Reijer
http://www.fda.gov/cder/orange/appendix_a.txt RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL I.V., METRONIDAZOLE HYDROCHLORIDE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HCL, FLAVOXATE HYDROCHLORIDE FLAXEDIL, GALLAMINE TRIETHIODIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLEXICORT, HYDROCORTISONE FLOLAN, EPOPROSTENOL SODIUM...
Prescription and Over-the-Counter Drug Product List: 2/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL -A- CODRIX -A- + ANDRX PHARMS 500MG;15MG N40447 001 FEB 26, 2003 FEB NEWA AZATHIOPRINE TABLET; ORAL AZASAN -A- AAIPHARMA LLC 25MG N75252 002 FEB 03, 2003 FEB NEWA -A- AB 50MG N75252 001 JUN 07, 1999 FEB NEWA -A- 75MG N75252 003 FEB 03, 2003 FEB NEWA -A- 100MG N75252 004 FEB 03, 2003...
author: AUTHOR
Microsoft Word - 2002 10k v13 3-21 Final.doc page 71
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 30
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 9
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 8
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 7
author: tlewis
SangStat page 34
author: Sangstat Medical
http://corpcomm.amgen.com/abgenix/releases/2003-02-18.html Study Of ABX- CBL In Steroid Resistant Graft Versus Host Disease Does Not Meet Primary Endpoint Fremont, CA February 18, 2003 SangStat Medical Corporation (Nasdaq: SANG) and Abgenix (Nasdaq: ABGX) disclosed today that Phase II/ III study results indicate ABX- CBL demonstrated a survival rate at 180 days in patients with acute steroid- resistant graft vs.
author: pmannle
http://corpcomm.amgen.com/abgenix/releases/2003-02-18.html page 2
author: pmannle
Canadian Medical Discoveries Fund Inc. CMDF Net Asset Value as of 04/19/04: $9.95 Genzyme to Acquire SangStat Medical Corporation Gains Leading Transplant Antibody Product, Strengthens Immunology Pipeline (August 4, 2003) CAMBRIDGE, Mass
Drug Approval Package FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - Gengraf Company:-Abbott Laboratories Application No.:-065003 Approval Date:-05/12/2000 Approval Letter(s) - Printed Labeling Chemistry Review(s) - Bioequivalence Review(s) - Administrative Document(s) - Correspondence - - Back to Drug Approval Page Some documents are in Portable...
Microsoft Word - 2002 10k v13 3-21 Final.doc page 72
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 70
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 62
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 53
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 37
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 36
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 35
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 31
author: tlewis
Microsoft Word - 2002 10k v13 3-21 Final.doc page 29
author: tlewis
